Abstract
Praziquantel is still very effective for the treatment of schistosomiasis, but there are rising concerns on the potential risk of developing resistances because of the extensive use of this drug. Triclabendazole, a systemic anthelmintic, is very effective against other trematodes such as Paragonimus spp. and Fasciola spp. It has been reported to be effective in vitro and in experimental animals against Schistosoma mansoni. However, its antischistosomal efficacy in humans has not yet been evaluated. The objective of the study was to evaluate the efficacy of triclabendazole at the dosage currently used for the treatment of human fascioliasis (10mg/kg body weight) in subjects co-infected with S. mansoni and Fasciola spp. The study was carried out in Behera, a highly endemic area for both parasites, by personnel of the Egyptian Ministry of Health and Population. Ten subjects (m = 4, f = 6; age, 8–58years), who were infected at the same time by Fasciola spp. and S. mansoni, were enrolled. Six weeks after therapy, seven subjects were still excreting ova of S. mansoni, whereas none was excreting Fasciola spp. ova. At the given dosage, triclabendazole appeared not to be sufficiently effective in the treatment of S. mansoni.
Similar content being viewed by others
References
Bundy DAP, Hall A, Medley GF, Savioli L (1992) Evaluating measures to control intestinal parasitic infections. World Health Stat Q 45:168–179
Calvopina M, Guderian RH, Paredes W, Cooper PJ (2003) Comparison of two single-day regimens of triclabendazole for the treatment of human pulmonary paragonimiasis. Trans R Soc Trop Med Hyg 97:451–454
Curtale F, Hassanein YAW, El Wakeel A, Barduagni P, Savioli L (2003) The school health programme in Behera: an integrated helminth control programme at governorate level in Egypt. Acta Trop 86:295–307
El Sayed MH, Allam AF, (1997) effect of triclabendazole on the tegument of Schistosoma mansoni: a scanning electron microscopic study.. J Egypt Soc Parasitol 7::43–152
Keiser J, El Ela NA, El Lakkany N, Diab T, Chollet J, Utzinger J, Barakat R (2006) Triclabendazole and its two main metabolites lack activity against Schistosoma mansoni in mouse model. Am J Trop Med Hyg 75:287–291
Khalil SS (2000) On the schistosomicidial effect of triclabendazole: an experimental study. J Egypt Soc Parasitol 30:799–808
Mansoury ST (1997) Effect of two trematodicidal drugs on the morphology and tegumentary ultrastructure of Schistosoma mansoni. J Egypt Soc Parasitol 27:233–241
Millán JC, Mull R, Freise S, Richter J, For the Triclabendazole Study Group (2000) The efficacy and tolerability of triclabendazole in Cuban patients with latent and chronic Fasciola hepatica infection. Am J Trop Med Hyg 63:264–269
Polman K, Stelma FF, Le Cessie S, De Vias SJ, Falcao Ferreira ST, Tallia I, Deelder AM, Gryseels B (2002) Evaluation of the patterns of Schistosoma mansoni infection and re-infection in Senegal, from faecal egg counts and serum concentrations of circulating anodic antigen. Ann Trop Med Parasitol 96:679–689
WHO (1994) Bench aids for the diagnosis of intestinal parasites. World Health Organization, Geneva
WHO (1995) WHO model prescribing information. Drugs used in parasitic diseases., 2nd edn. World Health Organization, Geneva
WHO (1998) Triclabendazole and fascioliasis—a new drug to combat an age-old disease. World Health Organization, Geneva (Fact sheet no. 191)
Acknowledgment
The present study was implemented in the framework of the Egyptian–Italian Cooperation Programme “Support to the Health Sector Reform” between the PHC Department of the MoHP, Egypt, and the DGCS–Ministry of Foreign Affairs, Italy. Special thanks to Prof. Joachim Richter, University of Düsseldorf, Germany, for his constant encouragement and support to the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barduagni, P., Hassanein, Y., Mohamed, M. et al. Use of triclabendazole for treatment of patients co-infected by Fasciola spp. and S. mansoni in Behera Governorate, Egypt. Parasitol Res 102, 631–633 (2008). https://doi.org/10.1007/s00436-007-0802-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-007-0802-6